Technology in Cancer Research and Treatment (TCRT) is a gold open access journal indexed in Clarivate Analytics: Science Citation Index Expanded (SCIE), PubMed Central (PMC), and PubMed: MEDLINE, among other indexing databases. The journal aim is to provide researchers and clinicians with a platform to share and discuss developments in the detection, diagnosis, prognosis, and treatment of cancer.

Article Types and Topics of Interest
TCRT welcomes original research, brief reports, reviews, mini-reviews, study protocols, and commentaries. We encourage submissions relating to advances in the following areas:

Diagnostic or Prognostic
Biomarkers (genes, genetic abnormalities, RNA, proteins, hormones, enzymes)
Methods of biomarker detection
Cancer biology (cell and molecular biology, immune response, tumor biology, tumor microenvironment)
Genetic (DNA damage and repair, epigenetics, gene regulation)
Proteomics, Genomics, Systems Biology
Drug discovery and development (new therapeutic targets, preclinical and clinical testing of new drugs
Epidemiology
Imaging technologies (CT scan, MRI, X-ray, Ultrasound)
Nuclear medicine scan (Bone, PET, Thyroid, MUGA, Gallium)
Biopsy (endoscopic, needle)
Emerging technologies
Novel applications of existing technologies

Treatment

Stem cell transplantation
Precision/Personalized medicine, Targeted therapy (antibodies, small-molecule drugs)
Immunotherapy (adoptive cell transfer, BCG, cytokines, gene therapy, gene transfer, monoclonal antibodies, oncolytic virotherapy, vaccines)
Surgery (open or minimally-invasive)
Chemotherapy
Hormone therapy
Radiation therapy (external beam or internal), Brachytherapy
Cryosurgery/Cryotherapy
Laser therapy (laser-induced interstitial thermotherapy (LITT), interstitial laser photocoagulation)
Hyperthermia therapy/Thermal therapy/Thermotherapy
Photodynamic therapy (PDT)
Pharmacotherapy (pharmacological treatments, drug delivery systems, pharmacokinetics, pharmacodynamics)
Irreversible electroporation (IRE)
Emerging technologies or novel applications of existing ones
TCRT only considers in silico studies that have robust external validation using an independent cohort or biological validation in vitro or in vivo and have potential clinical applications.

Click here to see a selection of the latest papers published in TCRT